Edward P. Browne, Ph.D. - Publications

Affiliations: 
2003 Princeton University, Princeton, NJ 
Area:
Molecular Biology

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Fenton AD, Archin N, Turner A-M, Joseph S, Moeser M, Margolis DM, Browne EP. A novel high-throughput microwell outgrowth assay for HIV-infected cells. Journal of Virology. e0179823. PMID 38376258 DOI: 10.1128/jvi.01798-23  0.337
2023 Cortés-Llanos B, Jain V, Cooper-Volkheimer A, Browne EP, Murdoch DM, Allbritton NL. Automated microarray platform for single-cell sorting and collection of lymphocytes following HIV reactivation. Bioengineering & Translational Medicine. 8: e10551. PMID 37693052 DOI: 10.1002/btm2.10551  0.372
2023 Cortés-Llanos B, Jain V, Volkheimer A, Browne EP, Murdoch DM, Allbritton NL. Automated microarray for single-cell sorting and collection of lymphocytes following HIV reactivation. Biorxiv : the Preprint Server For Biology. PMID 36778314 DOI: 10.1101/2023.02.02.526757  0.365
2021 Jefferys SR, Burgos SD, Peterson JJ, Selitsky SR, Turner AM, James LI, Tsai YH, Coffey AR, Margolis DM, Parker J, Browne EP. Epigenomic characterization of latent HIV infection identifies latency regulating transcription factors. Plos Pathogens. 17: e1009346. PMID 33635929 DOI: 10.1371/journal.ppat.1009346  0.391
2020 Nekongo EE, Ponomarenko AI, Dewal MB, Butty VL, Browne EP, Shoulders MD. HSF1 Activation Can Restrict HIV Replication. Acs Infectious Diseases. PMID 32502335 DOI: 10.1021/Acsinfecdis.0C00166  0.394
2020 Turner AM, Dronamraju R, Potjewyd FM, Sholtis K, Winecoff D, Kirchherr J, Archin N, Browne E, Strahl BD, Margolis D, James LI. Evaluation of EED Inhibitors as a Class of PRC2-Targeted Small Molecules for HIV Latency Reversal. Acs Infectious Diseases. PMID 32347704 DOI: 10.1021/Acsinfecdis.9B00514  0.431
2020 Nixon CC, Mavigner M, Sampey GC, Brooks AD, Spagnuolo RA, Irlbeck DM, Mattingly C, Ho PT, Schoof N, Cammon CG, Tharp GK, Kanke M, Wang Z, Cleary RA, Upadhyay AA, ... ... Browne EP, et al. Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo. Nature. PMID 31969707 DOI: 10.1038/S41586-020-1951-3  0.393
2019 Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, Chicoine A, Eisenhaure TM, Jonsson AH, Li S, Lieb DJ, Zhang F, Slowikowski K, Browne EP, Noma A, et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nature Immunology. PMID 31209404 DOI: 10.1038/S41590-019-0398-X  0.379
2019 Reyes M, Vickers D, Billman K, Eisenhaure T, Hoover P, Browne EP, Rao DA, Hacohen N, Blainey PC. Multiplexed enrichment and genomic profiling of peripheral blood cells reveal subset-specific immune signatures. Science Advances. 5: eaau9223. PMID 30746468 DOI: 10.1126/Sciadv.Aau9223  0.36
2019 Berthier CC, Arazi A, Rao D, Davidson A, Browne E, Eisenhaure T, Hacohen N, Lieb DJ, Diamond B, Kretzler M. 204 The immune cell landscape in kidneys of lupus nephritis patients Lupus Science & Medicine. 6. DOI: 10.1136/Lupus-2019-Lsm.204  0.356
2018 Bradley T, Ferrari G, Haynes BF, Margolis DM, Browne EP. Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency. Cell Reports. 25: 107-117.e3. PMID 30282021 DOI: 10.1016/J.Celrep.2018.09.020  0.464
2017 Berthier C, Rao D, Arazi A, Browne E, Eisenhaure T, Hacohen N, Lieb D, Diamond B, Kretzler M. 264 Pearl: pathway exploration and analysis in renal disease in the accelerating medicine partnership (amp) lupus network Lupus Science & Medicine. 4. DOI: 10.1136/Lupus-2017-000215.264  0.324
2016 Cadena C, Stavrou S, Manzoni T, Iyer SS, Bibollet-Ruche F, Zhang W, Hahn BH, Browne EP, Ross SR. The effect of HIV-1 Vif polymorphisms on A3G anti-viral activity in an in vivo mouse model. Retrovirology. 13: 45. PMID 27363431 DOI: 10.1186/S12977-016-0280-Y  0.405
2016 Browne EP, Letham B, Rudin C. A Computational Model of Inhibition of HIV-1 by Interferon-Alpha. Plos One. 11: e0152316. PMID 27010978 DOI: 10.1371/Journal.Pone.0152316  0.434
2016 Tas JM, Mesin L, Pasqual G, Targ S, Jacobsen JT, Mano YM, Chen CS, Weill JC, Reynaud CA, Browne EP, Meyer-Hermann M, Victora GD. Visualizing antibody affinity maturation in germinal centers. Science (New York, N.Y.). PMID 26912368 DOI: 10.1126/Science.Aad3439  0.303
2015 Browne EP. An interleukin-1 beta-encoding retrovirus exhibits enhanced replication in vivo. Journal of Virology. 89: 155-64. PMID 25320301 DOI: 10.1128/Jvi.02314-14  0.302
2014 Stavrou S, Crawford D, Blouch K, Browne EP, Kohli RM, Ross SR. Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo. Plos Pathogens. 10: e1004145. PMID 24851906 DOI: 10.1371/Journal.Ppat.1004145  0.402
2013 Browne EP. Toll-like receptor 7 inhibits early acute retroviral infection through rapid lymphocyte responses. Journal of Virology. 87: 7357-66. PMID 23616654 DOI: 10.1128/Jvi.00788-13  0.405
2012 Browne EP. Regulation of B-cell responses by Toll-like receptors. Immunology. 136: 370-9. PMID 22444240 DOI: 10.1111/J.1365-2567.2012.03587.X  0.386
2012 Nassar RA, Browne EP, Chen J, Klibanov AM. Removing human immunodeficiency virus (HIV) from human blood using immobilized heparin. Biotechnology Letters. 34: 853-6. PMID 22207147 DOI: 10.1007/S10529-011-0840-0  0.361
2011 Browne EP. Toll-like receptor 7 controls the anti-retroviral germinal center response. Plos Pathogens. 7: e1002293. PMID 21998589 DOI: 10.1371/Journal.Ppat.1002293  0.388
2009 Browne EP, Allers C, Landau NR. Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent. Virology. 387: 313-21. PMID 19304304 DOI: 10.1016/J.Virol.2009.02.026  0.414
2009 Browne EP, Littman DR. Myd88 is required for an antibody response to retroviral infection. Plos Pathogens. 5: e1000298. PMID 19214214 DOI: 10.1371/Journal.Ppat.1000298  0.402
2008 Browne EP, Littman DR. Species-specific restriction of apobec3-mediated hypermutation. Journal of Virology. 82: 1305-13. PMID 18032489 DOI: 10.1128/Jvi.01371-07  0.355
2005 Browne EP, Li J, Chong M, Littman DR. Virus-host interactions: new insights from the small RNA world. Genome Biology. 6: 238. PMID 16277756 DOI: 10.1186/Gb-2005-6-11-238  0.328
2004 Challacombe JF, Rechtsteiner A, Gottardo R, Rocha LM, Browne EP, Shenk T, Altherr MR, Brettin TS. Evaluation of the host transcriptional response to human cytomegalovirus infection. Physiological Genomics. 18: 51-62. PMID 15069167 DOI: 10.1152/Physiolgenomics.00155.2003  0.535
2003 Browne EP, Shenk T. Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proceedings of the National Academy of Sciences of the United States of America. 100: 11439-44. PMID 12972646 DOI: 10.1073/Pnas.1534570100  0.564
2001 Browne EP, Wing B, Coleman D, Shenk T. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. Journal of Virology. 75: 12319-30. PMID 11711622 DOI: 10.1128/Jvi.75.24.12319-12330.2001  0.545
2001 Wing BA, Browne EP, Shenk T. DNA microarrays: A powerful new tool for analysis of the virus-host interaction Drug Discovery Today. 6.  0.3
Show low-probability matches.